Canada · 
Who invested in Interface Biologics, Inc.?
Interface Biologics, Inc.'s investors include BDC Capital, DSM Venturing and Covington Group.
2009201020112012201320142015
$5.0MVenture$19MSeries A$7.0MSeries B$1.0MVenture?Series BCanada · Series B startup
Who invested in Interface Biologics, Inc.
5 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$32Mraised across 5 rounds since 2008, from 5 sources
$5.0MVenture$19MSeries A$7.0MSeries B$1.0MVenture
- Latest round
- Series BJan 2015
- Biggest round
- $19MSeries A · Jan 2010
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $5.0M Dec 2008
- Biggest round
- $19M Series A · Jan 2010
- Usual gap between rounds
- 13 months the median of 4
The rounds
- Jan 2015
- Dec 2011
- Jan 2011
- Jan 2010Series A$19M
No investor was named in the report.
From a historical funding record
- Dec 2008
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Interface Biologics, Inc.
How much has Interface Biologics, Inc. raised?
Interface Biologics, Inc. has raised $32M across 5 rounds since 2008. One round did not disclose an amount, so the total is a floor.
When did Interface Biologics, Inc. last raise?
Interface Biologics, Inc.'s most recent round was a Series B in Jan 2015.
What was Interface Biologics, Inc.'s biggest round?
Interface Biologics, Inc.'s largest round on record is $19M (Series A), in Jan 2010.
Who backed Interface Biologics, Inc. first?
Interface Biologics, Inc.'s first round on record, in Dec 2008, was backed by BDC Capital and Covington Group.
What stage is Interface Biologics, Inc. at?
Interface Biologics, Inc.'s latest named round is a Series B, in Jan 2015.
Where is Interface Biologics, Inc. based?
Interface Biologics, Inc. is based in Canada.
Companies like Interface Biologics, Inc.
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.